Log on / register
Feedback | Support | My details
Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin.
Wang JY, Roehrl MH
Med Immunol 2005 Mar 24, 4:4
[Full text] [PubMed] [Related articles]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine.
Zeng M, Xu Q, Pichichero ME
Vaccine 2007 May 4, 25:3588-94
 [PubMed Central] [PubMed] [Related articles]
2.
Anthrax vaccine and public health policy.
Weiss MM, Weiss PD, Weiss JB
Am J Public Health 2007 Nov, 97:1945-51
 [PubMed Central] [PubMed] [Related articles]
3.
Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
Yan M, Roehrl MH, Basar E, Wang JY
Vaccine 2008 Feb 13, 26:947-55
 [PubMed Central] [PubMed] [Related articles]
4.
Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
Nguyen ML, Crowe SR, Kurella S, Teryzan S, Cao B, Ballard JD, James JA, Farris AD
Infect Immun 2009 Jan, 77:162-9
 [PubMed Central] [PubMed] [Related articles]
5.
A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge.
Klas SD, Petrie CR, Warwood SJ, Williams MS, Olds CL, Stenz JP, Cheff AM, Hinchcliffe M, Richardson C, Wimer S
Vaccine 2008 Oct 9, 26:5494-502
 [PubMed Central] [PubMed] [Related articles]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.